Clinical Practice of Allergen Immunotherapy for Allergic Rhinoconjunctivitis and Asthma: An Expert Panel Report.

Allergens Asthma / therapy Desensitization, Immunologic Humans Rhinitis, Allergic / therapy
Allergic rhinitis Allergy immunotherapy Asthma Clinical practice Guidelines

Journal

The journal of allergy and clinical immunology. In practice
ISSN: 2213-2201
Titre abrégé: J Allergy Clin Immunol Pract
Pays: United States
ID NLM: 101597220

Informations de publication

Date de publication:
10 2020
Historique:
received: 12 12 2019
revised: 13 03 2020
accepted: 20 04 2020
pubmed: 19 5 2020
medline: 15 5 2021
entrez: 19 5 2020
Statut: ppublish

Résumé

Allergen immunotherapy (AIT) reduces symptoms and medication use associated with allergic rhinitis with or without conjunctivitis and allergic asthma. Although several AIT guidelines exist, there remain unanswered questions about AIT that are relevant to everyday practice. Our objective was to prepare an evidence-based overview addressing the practical aspects of AIT in clinical practice based on published evidence and the experience of international experts in the field. Topics covered include interpretation and translation of clinical trial data into everyday clinical practice (eg, allergen doses and treatment duration), assessment of risk and treatment of local and systemic allergic reactions, recommendations for improvement of AIT guidelines, and identification of appropriate data for seeking regulatory approval, to name a few. Many informational gaps in AIT practice need further evaluation as products and practices evolve.

Identifiants

DOI: 10.1016/j.jaip.2020.04.071 PMID: 32422372
pubmed: 32422372
pii: S2213-2198(20)30479-7
doi: 10.1016/j.jaip.2020.04.071
pii:
doi:

Substances chimiques

Allergens 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2920-2936.e1

Informations de copyright

Copyright © 2020. Published by Elsevier Inc.

Auteurs

Moisés A Calderon (MA)

Section of Allergy and Clinical Immunology, Imperial College London-NHLI, London, United Kingdom. Electronic address: m.calderon@imperial.ac.uk.

Susan Waserman (S)

Department of Medicine, McMaster University, Hamilton, ON, Canada.

David I Bernstein (DI)

Division of Allergy, Rheumatology and Immunology, Department of Medicine, University of Cincinnati, Cincinnati, Ohio.

Pascal Demoly (P)

Department of Pulmonology, University Hospital of Montpellier, & IPLESP, Sorbonne Université - Inserm, Paris, France.

Jo Douglass (J)

The Royal Melbourne Hospital & The University of Melbourne, Melbourne, VIC, Australia.

Remi Gagnon (R)

Clinique Spécialisée en Allergie de la Capitale, Québec, QC, Canada.

Constance H Katelaris (CH)

Campbelltown Hospital and the School of Medicine, Western Sydney University, Sydney, NSW, Australia.

Harold Kim (H)

Division of Clinical Immunology and Allergy, Western University, London, ON, Canada; Division of Clinical Immunology & Allergy, Department of Medicine, McMaster University, Hamilton, ON, Canada.

Harold S Nelson (HS)

Department of Medicine, National Jewish Health, Denver, Colo.

Yoshitaka Okamoto (Y)

Department of Otorhinolaryngology, Chiba University Hospital, Chiba, Japan.

Kimihiro Okubo (K)

Department of Otolaryngology, Nippon Medical School, Nippon, Japan.

J Christian Virchow (JC)

Department of Pneumology/Intensive Care Medicine, University of Rostock, Rostock, Germany.

Lawrence DuBuske (L)

Department of Medicine, Division of Allergy and Immunology, The George Washington University School of Medicine and Health Sciences, Washington, DC.

Thomas B Casale (TB)

Division of Allergy/Immunology, University of South Florida, Tampa, Fla.

G Walter Canonica (GW)

Personalized Medicine Clinic Asthma & Allergy, Humanitas Clinical and Research Center, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.

Hendrik Nolte (H)

ALK, Bedminster, NJ.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Facteurs biologiques › Antigènes › Allergènes › Clinical Practice of Allergen Immunotherapy...
questionsmedicales.fr › Maladies du système immunitaire › Hypersensibilité › Hypersensibilité immédiate › Hypersensibilité respiratoire › Asthme › Clinical Practice of Allergen Immunotherapy...
questionsmedicales.fr › Techniques d'investigation › Techniques immunologiques › Immunosuppression thérapeutique › Désensibilisation immunologique › Clinical Practice of Allergen Immunotherapy...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Clinical Practice of Allergen Immunotherapy...
questionsmedicales.fr › Maladies du système immunitaire › Hypersensibilité › Hypersensibilité immédiate › Hypersensibilité respiratoire › Rhinite allergique › Clinical Practice of Allergen Immunotherapy...